Most cited articles

  • HOME
  • BROWSE ARTICLES
  • Most cited articles

From articles published in Journal of Urologic Oncology during the past two years (2023 ~ ).

The Landscape of Epidemiology in Urologic Cancers
Original Article
535
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Sang Heon Han, Hyeong Dong Yuk
Journal of Urologic Oncology. 2023;21(1):32-44.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Review Article
532
Complex Epidemiology of Prostate Cancer in Asian Countries
Kagenori Ito, Takahiro Kimura
Journal of Urologic Oncology. 2023;21(1):5-13.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Prostate Cancer
Invited Review
569
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Chang Wook Jeong
Journal of Urologic Oncology. 2024;22(1):4-10.   Published online March 31, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Invited Review
Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, Weerachai Jaratlerdsiri, Mukudeni Nenzhelele, Mulalo B. Radzuma, Kazzem Gheybi, Winstar Mokua, Micah O. Oyaro, Daniel M. Moreira, Ikenna C. Madueke, HEROIC PCaPH AfricaK Consortium, Shingai B.A. Mutambirwa, Gail S. Prins, Mungai P. Ngugi, M.S. Riana Bornman
Journal of Urologic Oncology. 2024;22(2):144-149.   Published online July 31, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Original Article
542
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
Jung Sik Huh, Kyung Kgi Park
Journal of Urologic Oncology. 2023;21(2):121-127.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
Invited Review
545
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Sang Hun Song, Jong Jin Oh
Journal of Urologic Oncology. 2023;21(2):154-164.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Kidney Cancer
Original Article
574
Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
Jung Hoon Kim, Ji Woong Hwang
Journal of Urologic Oncology. 2024;22(1):42-51.   Published online March 31, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Invited Review
550
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Byung Kwan Park
Journal of Urologic Oncology. 2023;21(2):106-111.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Bladder Cancer
Invited Review
599
Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Yongsoo Jo, Hyeong Dong Yuk
Journal of Urologic Oncology. 2024;22(3):256-267.   Published online November 30, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Review Article
533
Current Update on Prostate Cancer Immunotherapy
Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
Journal of Urologic Oncology. 2023;21(1):14-22.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
536
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database
Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, Woo Suk Choi, Yun-Sok Ha, Jeong Hyun Kim, Cheol Kwak
Journal of Urologic Oncology. 2023;21(1):45-52.   Published online March 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
Original Article
547
The Predictive Value of the Preoperative Systemic Inflammatory Response Indices in Non–Organ-Confined Disease in Upper Urinary Tract Urothelial Carcinoma
Sung Kyung Choi, Chan Hoon Gwak, Jungyo Suh, Bumjin Lim, Cheryn Song, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Bumsik Hong, Choung-Soo Kim, Hanjong Ahn
Journal of Urologic Oncology. 2023;21(2):174-180.   Published online July 31, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Invited Review
553
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma
Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, Mehmet A. Bilen, Kenneth Ogan, Viraj A. Master
Journal of Urologic Oncology. 2023;21(3):183-199.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Invited Review
556
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
Chan Woo Wee, Jaeho Cho
Journal of Urologic Oncology. 2023;21(3):217-227.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
Invited Review
557
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
Jiwoong Yu, Hyun Hwan Sung
Journal of Urologic Oncology. 2023;21(3):228-240.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043



Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.

Developed in M2PI